Targeted Genetics began human clinical testing using gene therapy to combat HIV infection
In 1993, Targeted Genetics, a subsidiary of the Immunex Corporation, became the first company to begin human clinical testing using gene therapy to combat HIV infection.
Gene therapy broadly involves the delivery of DNA encoding many different types of proteins.
Tags:
Source: Journal of Allergy and Clinical Immunology
Credit:
